IN
Intelligent Bio Solutions Inc.
INBS · NASDAQ
$1.91 -1.55% (-$0.03)
1M -26.42%
Market Cap $1.29M
P/E Ratio -
Div. Yield -
ROE 170.37%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.23x
P/S 0.31x
EV/FFO N/A
Growth
99 /100
Growing Book val. growth 13.20%
Rev. growth 49.68%
FCF growth N/A
Profitability
19 /100
Weak Op. margin 299.11%
Gross margin 48.63%
FCF margin 289.53%
Quality
4 /100
Poor ROA 104.10%
ROIC 176.09%
Asset turnover 0.35x
Debt
61 /100
Moderate Int. coverage -1,160.39x
Debt/Equity 0.33x
Current ratio 1.44x
Stability
31 /100
Unstable EPS volatility 14.63%
Beta 4.25x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about INBS
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Harry Simeonidis
Employees
58
Headquarters
New York City
Upcoming events
11 NOV
Earnings
Upcoming earnings report